224 related articles for article (PubMed ID: 19562872)
1. [Application of recombinant activated factor VII in treatment of intracranial haemorrhage in haemophilic patient with inhibitor].
Antić D; Elezović I; Sufajdzić N; Todorović M; Bila J; Mitrović M; Andjelkovic N
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():218-21. PubMed ID: 19562872
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008).
Nakar C; Cooper DL; DiMichele D
Haemophilia; 2010 Jul; 16(4):625-31. PubMed ID: 20158526
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
Scharrer I
Haemophilia; 1999 Jul; 5(4):253-9. PubMed ID: 10469179
[TBL] [Abstract][Full Text] [Related]
4. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
Meili EO; Dazzi H; von Felten A
Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
[TBL] [Abstract][Full Text] [Related]
6. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Karimi M
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
[TBL] [Abstract][Full Text] [Related]
7. [Rehabilitation in haemophilic children with inhibitors using recombinant activated factor VII].
Janić D; Petronić I; Dokmanović L; Krstovski N; Lazić J; Rodić P
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():226-30. PubMed ID: 19562874
[TBL] [Abstract][Full Text] [Related]
8. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
[TBL] [Abstract][Full Text] [Related]
9. Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors.
Polyanskaya T; Zorenko V; Karpov E; Sampiev M; Mishin G; Vasiliev D
Haemophilia; 2012 Nov; 18(6):997-1002. PubMed ID: 22672066
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
Schmidt ML; Gamerman S; Smith HE; Scott JP; DiMichele DM
Am J Hematol; 1994 Sep; 47(1):36-40. PubMed ID: 8042614
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant factor VIIa (NovoSeven). A review of current and possible future indications].
Heuer L; Blumenberg D
Anaesthesist; 2002 May; 51(5):388-99. PubMed ID: 12125311
[TBL] [Abstract][Full Text] [Related]
12. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
Valentino LA; Cooper DL; Goldstein B
Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
[TBL] [Abstract][Full Text] [Related]
13. Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children.
Herbertson M; Kenet G
Haemophilia; 2008 Jul; 14(4):753-62. PubMed ID: 18445016
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.
Petrini P; Klementz G
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S143-6. PubMed ID: 9819046
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.
Amano K; Seita I; Higasa S; Sawada A; Kuwahara M; Shima M
Haemophilia; 2017 Jan; 23(1):50-58. PubMed ID: 27457022
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
17. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
18. [Acquired haemophilia A presenting in postpartum period--case report].
Mitrović-Vasiljević M; Antić D; Elezović I; Bila J; Todorović M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():214-7. PubMed ID: 19562871
[TBL] [Abstract][Full Text] [Related]
19. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
20. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L
Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
